Nexavar
Nexavar Official FDA information, side effects and uses.
Posted by Nexavar (Nexavar) on Sun, 12 Aug 2007 00:15:22 +0000
Bayer Schering has reported robust second quarter sales, and an overall positive performance during the first half of the year, boosted by strong product lines such as Yasmin and Betaferon which were gained from the acquisition of Schering AG in 2006. However, the leading German pharmaceutical companys future focus relies heavily on the new oncology treatment Nexavar.
Onyx shares up after Bayer announces Nexavar sales (Reuters via Yahoo! Singapore News)
LOS ANGELES, Aug 7 - Shares in Onyx Pharmaceuticals Inc. rose as much a 9 percent after partner Bayer reported a 161 rise in sales of their cancer drug Nexavar.
Onyx Shines on Nexavar Sales (TheStreet.com)
Strong demand for the kidney-cancer drug sends shares up 8%.
Onyx Pharmaceuticals 2Q Loss Narrows (AP via Yahoo! Finance)
Onyx Pharmaceuticals Inc. said late Tuesday its second-quarter loss narrowed on lower operating expenses and a payment from Bayer for the liver cancer drug Nexavar.
Elderly parents of cancer sufferer forced to sell home to fund treatment (Daily Mail)
The elderly parents of a man denied a life-prolonging cancer drug said they will sell their home to help him survive. Ken and Irene Potts, both 78, said they would 'live in a tent' if the drug could help their sick son Ken
